Universe Pharmaceuticals INC (UPC) stock forecast & analysis
4.30
NasdaqCM · USD
Down: -0.48, -10.0%
4.75Up: +0.45, +10.5%
1 analysis
Use Arrow keys to explore price history; Home and End jump to the oldest and newest points
- Open
- 4.51
- Previous close
- 4.78
- Day range
- 4.25 – 4.74
- 52-week range
- 2.00 – 17.96
- Volume (shares)
- 129.86K
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 5.01M
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- 1.59
- Market cap
- 21.60M
Market Scanner’s AI analysis of Universe Pharmaceuticals INC (UPC), updated June 2026: UPC's recent analysis covered a significant acquisition, extreme technical overbought conditions, and declining revenue.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Universe Pharmaceuticals INC (UPC) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
UPC's recent analysis covered a significant acquisition, extreme technical overbought conditions, and declining revenue.
Recent analyses for UPC focused on a major acquisition of Best Praise International, which drove a substantial after-hours price surge. This was juxtaposed with technical indicators showing extreme overbought conditions and a moderate volatility. Fundamentally, the company reported declining year-over-year quarterly revenue and negative profitability metrics.
Factors discussed — upside
- Retail investor sentiment on StockTwits shows a predominantly bullish lean.
- Significant price surge of 288% after hours linked to acquisition news.
- MACD indicates bullish momentum.
- RSI and MFI show strong upward momentum and buying pressure.
Factors discussed — risks
- Year-over-year quarterly revenue decline of 14.1%.
- Deeply negative TTM profit margin (-20.562%), operating margin (-6.767%), and return on equity (-7.226%).
- Extremely overbought conditions indicated by RSI and MFI.
- Stock trading below its 50-day and 200-day moving averages.
- Acquisition impact
- Technical indicators
- Revenue trends
- Profitability metrics
Summary updated .
UPC technical indicators
Common technical indicators for UPC, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 4.84 | Price below |
| 10-day exponential moving average | 4.59 | Price below |
| Relative strength index (14-day) | 43.52 | Neutral |
| MACD line (12/26/9) | -0.0765 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 3.96 – 5.08 | Price inside the bands |
Frequently asked questions
- What is the bull case for Universe Pharmaceuticals INC?
- The bull case for UPC centers on strong upward momentum indicated by technical indicators like the MACD, RSI, and MFI, alongside predominantly bullish retail investor sentiment. A significant after-hours price surge following the announcement of an acquisition of Best Praise International also contributed to the positive outlook.
- What are the risks for Universe Pharmaceuticals INC?
- Risks for UPC include a year-over-year quarterly revenue decline and deeply negative profitability metrics, such as TTM profit margin and operating margin. The company's stock is also trading below its longer-term moving averages, and technical indicators show extremely overbought conditions.
- Is Universe Pharmaceuticals INC bullish or bearish?
- Recent AI analyses of Universe Pharmaceuticals INC examined factors on both sides. Discussed upside: The bull case for UPC centers on strong upward momentum indicated by technical indicators like the MACD, RSI, and MFI, alongside predominantly bullish retail investor sentiment. A significant after-hours price surge following the announcement of an acquisition of Best Praise International also contributed to the positive outlook. Discussed risks: Risks for UPC include a year-over-year quarterly revenue decline and deeply negative profitability metrics, such as TTM profit margin and operating margin. The company's stock is also trading below its longer-term moving averages, and technical indicators show extremely overbought conditions. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Universe Pharmaceuticals INC?
- Recent analyses for UPC focused on a major acquisition of Best Praise International, which drove a substantial after-hours price surge. This was juxtaposed with technical indicators showing extreme overbought conditions and a moderate volatility. Fundamentally, the company reported declining year-over-year quarterly revenue and negative profitability metrics.
- How does Market Scanner analyse Universe Pharmaceuticals INC?
- Every analysis of Universe Pharmaceuticals INC runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
- Bundles used
- gemini-low-v2
Run a fresh UPC analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.